Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Blickenstorfer

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Praxis|February 3, 2021
[An Itching Pleasure]Gioia Braun-Meyre, Corinne Marbet, Marcel Blickenstorfer, et al.
Dermatology Online Journal|February 22, 2023
Linear IgA bullous dermatosis of childhoodJasmin Nasri, Pierre Jungo, Marcel Blickenstorfer, et al.
Swiss Medical Weekly|June 2, 2011
Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experiencePanagiotis Samaras, Marcel Blickenstorfer, Sarah R Haile, et al.
Annals of Hematology|August 14, 2010
Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastimPanagiotis Samaras, Marcel Blickenstorfer, Raffaele Daniele Siciliano, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Praxis|February 3, 2021
[An Itching Pleasure]Gioia Braun-Meyre, Corinne Marbet, Marcel Blickenstorfer, et al.
Dermatology Online Journal|February 22, 2023
Linear IgA bullous dermatosis of childhoodJasmin Nasri, Pierre Jungo, Marcel Blickenstorfer, et al.
Swiss Medical Weekly|June 2, 2011
Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experiencePanagiotis Samaras, Marcel Blickenstorfer, Sarah R Haile, et al.
Annals of Hematology|August 14, 2010
Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastimPanagiotis Samaras, Marcel Blickenstorfer, Raffaele Daniele Siciliano, et al.
Pageof 1